{
    "clinical_study": {
        "@rank": "127726", 
        "arm_group": [
            {
                "arm_group_label": "Glucose 10g", 
                "arm_group_type": "Active Comparator", 
                "description": "10g Glucose in 200ml tap water given orally (plus 50 mg 13C-sodium acetate)via nasogastric tube"
            }, 
            {
                "arm_group_label": "Glucose 25g", 
                "arm_group_type": "Active Comparator", 
                "description": "25g Glucose in 200ml tap water given orally (plus 50 mg 13C-sodium acetate)via nasogastric tube"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "intragastric tap water"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to examine gastric emptying and satiety hormones after oral\n      glucose stimulation in 2 different concentrations in normal-weight and obese patients."
        }, 
        "brief_title": "Oral Glucose Stimulation in Normal-weight and Obese Volunteers", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Endocrine System Diseases", 
        "condition_browse": {
            "mesh_term": "Endocrine System Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy normal weight subjects with a body-mass index of 19.0-24.5 or healthy obese\n             subjects with a body-mass index of > 30\n\n          -  Normal eating habits\n\n          -  Age 18-40 years\n\n          -  Stable body weight for at least three months\n\n        Exclusion Criteria:\n\n          -  Smoking\n\n          -  Substance abuse\n\n          -  Regular intake of medications (except for oral contraceptives)\n\n          -  Medical or psychiatric illness\n\n          -  Any abnormality detected during the screening procedure\n\n          -  history of gastrointestinal disorders\n\n          -  food allergies"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01875575", 
            "org_study_id": "EKBB 08/11"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Glucose 25g", 
                "intervention_name": "Glucose 25g", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Glucose 10g", 
                "intervention_name": "Glucose 10g", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "glucagon-like peptide-1", 
            "peptide tyrosine tyrosine", 
            "ghrelin", 
            "stomach", 
            "small intestine", 
            "gastric emptying"
        ], 
        "lastchanged_date": "June 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Basel", 
                    "country": "Switzerland", 
                    "zip": "CH-4031"
                }, 
                "name": "University Hospital Basel"
            }
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "3", 
        "official_title": "Oral Glucose in Normal-weight and Obese Volunteers", 
        "overall_official": {
            "affiliation": "University Hospital, Basel, Switzerland", 
            "last_name": "Christoph Beglinger, Prof", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Plasma concentrations of glucose, insulin, glucagon, ghrelin, GLP-1, PYY and CCK are measured", 
            "measure": "Effect of different oral glucose loads on secretion of satiation hormones", 
            "safety_issue": "No", 
            "time_frame": "240min."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01875575"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "measured by C13 breath test", 
            "measure": "Effect of different oral glucose loads on gastric emptying", 
            "safety_issue": "No", 
            "time_frame": "240min."
        }, 
        "source": "University Hospital, Basel, Switzerland", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Basel, Switzerland", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}